Hepatitis B Leading to Megaloblastic Anemia and Catastrophic Peripheral Thrombocytopenia

被引:1
作者
Hafeez, Muhammad [1 ]
Sarfraz, Tariq [2 ]
Khan, Raja Ghayas [3 ]
Rafe, Abdul [4 ]
Rasool, Ghulam [5 ]
Ahmed, Kamran Nazir [6 ]
机构
[1] Combined Mil Hosp, Dept Gastroenterol, Kharian, Pakistan
[2] Combined Mil Hosp, Pathol, Kharian, Pakistan
[3] Combined Mil Hosp, Med, Kharian, Pakistan
[4] Combined Mil Hosp, Ophthalmol, Kharian, Pakistan
[5] Combined Mil Hosp, Cardiol, Kharian, Pakistan
[6] Combined Mil Hosp, Haematol, Kharian, Pakistan
来源
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN | 2016年 / 26卷 / 12期
关键词
Hepatitis B; Thrombocytopenia; Megaloblastic anemia;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hepatitis B virus (HBV) typically causes chronic hepatitis, cirrhosis, and hepatocellular carcinoma. It is associated with a variety of extrahepatic complications. We herein, present a rare extrahepatic complication of HBV infection. A 32-year man presented with melena, bleeding from gums and fever. Peripheral blood examination revealed anemia, macrocytosis and severe thrombocytopenia. His hepatitis B surface antigen (HBsAg) was positive but deoxyribonucleic acid (HBV DNA) by polymerase chain reaction (PCR) was negative. Other hepatitis, human immune deficiency virus (HIV), dengue, and autoimmune serology were negative. Bone marrow examination revealed megaloblastic erythropoiesis. There was mild to moderate reduction of megakaryocytes in bone marrow, which was not compatible with severe peripheral thrombocytopenia. His response to, cyanocobalamin and folic acid was remarkable for myeloid cell lines and moderate for erythroid cell lines, but poor to platelet counts. Platelet counts gradually improved to safe limits with eltrombopag, likely reflecting autoimmune pathogenesis for thrombocytopenia. This case report highlights multiple targets of HBV infection with associated multiple pathogenetic mechanisms.
引用
收藏
页码:992 / 994
页数:3
相关论文
共 11 条
[1]   Epidemiology and prevention of hepatitis B [J].
Alter, MJ .
SEMINARS IN LIVER DISEASE, 2003, 23 (01) :39-46
[2]  
Andres E, 2011, HEPAT MON, V11, P206
[3]  
Baig S, 2008, JCPSP-J COLL PHYSICI, V18, P451, DOI 07.2008/JCPSP.451457
[4]  
Behnava B., 2006, Hepatitis Monthly, V6, P67
[5]   Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura [J].
Bussel, James B. ;
Cheng, Gregory ;
Saleh, Mansoor N. ;
Psaila, Bethan ;
Kovaleva, Lidia ;
Meddeb, Balkis ;
Kloczko, Janusz ;
Hassani, Habib ;
Mayer, Bhabita ;
Stone, Nicole L. ;
Arning, Michael ;
Provan, Drew ;
Jenkins, Julian M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (22) :2237-2247
[6]   Eltrombopag [J].
Garnock-Jones, Karly P. ;
Keam, Susan J. .
DRUGS, 2009, 69 (05) :567-576
[7]  
Han Steven-Huy B, 2004, Clin Liver Dis, V8, P403, DOI 10.1016/j.cld.2004.02.003
[8]  
Kumar S, 2013, JIACM, V14, P169
[9]   Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C [J].
McHutchison, John G. ;
Dusheiko, Geoffrey ;
Shiffman, Mitchell L. ;
Rodriguez-Torres, Maribel ;
Sigal, Samuel ;
Bourliere, Marc ;
Berg, Thomas ;
Gordon, Stuart C. ;
Campbell, Fiona M. ;
Theodore, Dickens ;
Blackman, Nicole ;
Jenkins, Julian ;
Afdhal, Nezam H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (22) :2227-2236
[10]   HEPATITIS-B VIRUS DIFFERENTIALLY SUPPRESSES MYELOPOIESIS AND DISPLAYS TROPISM FOR IMMATURE HEMATOPOIETIC-CELLS [J].
SING, GK ;
PRIOR, S ;
FERNAN, A ;
COOKSLEY, G .
JOURNAL OF VIROLOGY, 1993, 67 (06) :3454-3460